Document is current
Any future updates will be listed below
-
Authors
Parry, M. G.
Cowling, T. E.
Sujenthiran, A.
Nossiter, J.
Berry, B.
Cathcart, P.
Aggarwal, A.
Payne, H.
van der Meulen, J.
Clarke, N. W.
Gnanapragasam, V. J.
-
Funding
Funding for this research was provided by:
Research Trainees Coordinating Centre (DRF-2018-11-ST2-036)
Medical Research Council (MR/S020470/1)
- License Information
-
More Information
Article History
Received: 28 January 2020
Accepted: 7 April 2020
First Online: 28 May 2020
Ethics approval and consent to participate
: All patient data used is fully anonymised and is therefore exempt from the UK National Research Ethics Committee (NREC) approval.
: Not applicable
: JvdM reports a contract with the Healthcare Quality Improvement Partnership (HQIP) (ExternalRef removed) for the provision of the National Prostate Cancer Audit (ExternalRef removed). HP has attended and received honoraria for advisory boards and travel expenses to medical meetings and served as a consultant for AstraZeneca, Astellas, Janssen, Sanofi Aventis, Takeda, Ipsen, Ferring, Sandoz, and Novartis. NWC has attended and received honoraria for advisory boards and travel expenses to medical meetings and served as a consultant for AstraZeneca, Astellas, Bayer, Janssen, Sanofi Aventis, Takeda, Ipsen, and Ferring.
